Hyperparathyroidism, Primary
"Hyperparathyroidism, Primary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition of abnormally elevated output of PARATHYROID HORMONE due to parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. It is characterized by the combination of HYPERCALCEMIA, phosphaturia, elevated renal 1,25-DIHYDROXYVITAMIN D3 synthesis, and increased BONE RESORPTION.
Concept/Terms
Hyperparathyroidism, Primary- Hyperparathyroidism, Primary
- Hyperparathyroidisms, Primary
- Primary Hyperparathyroidisms
- Primary Hyperparathyroidism
Below are MeSH descriptors whose meaning is more general than "Hyperparathyroidism, Primary".
Below are MeSH descriptors whose meaning is more specific than "Hyperparathyroidism, Primary".
This graph shows the total number of publications written about "Hyperparathyroidism, Primary" by people in Harvard Catalyst Profiles by year, and whether "Hyperparathyroidism, Primary" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 4 | 0 | 4 |
2007 | 3 | 0 | 3 |
2008 | 3 | 3 | 6 |
2009 | 8 | 2 | 10 |
2010 | 1 | 1 | 2 |
2011 | 6 | 2 | 8 |
2012 | 8 | 1 | 9 |
2013 | 9 | 1 | 10 |
2014 | 8 | 0 | 8 |
2015 | 3 | 0 | 3 |
2016 | 5 | 0 | 5 |
2017 | 2 | 0 | 2 |
2018 | 5 | 0 | 5 |
2019 | 6 | 0 | 6 |
2020 | 5 | 0 | 5 |
2021 | 4 | 0 | 4 |
2022 | 12 | 0 | 12 |
Below are the most recent publications written about "Hyperparathyroidism, Primary" by people in Profiles.
-
How low is too low? Intraoperative parathyroid hormone decline in normohormonal primary hyperparathyroidism. Surgery. 2023 Jan; 173(1):166-172.
-
Management of Primary Hyperparathyroidism. J Bone Miner Res. 2022 11; 37(11):2391-2403.
-
The Efficacy and Safety of Medical and Surgical Therapy in Patients With Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Bone Miner Res. 2022 11; 37(11):2351-2372.
-
Methodology for the Guidelines on Evaluation and Management of Hypoparathyroidism and Primary Hyperparathyroidism. J Bone Miner Res. 2022 11; 37(11):2404-2410.
-
Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. J Bone Miner Res. 2022 11; 37(11):2293-2314.
-
The Fifth International Workshop on the Evaluation and Management of Primary Hyperparathyroidism. J Bone Miner Res. 2022 11; 37(11):2290-2292.
-
Classical and Nonclassical Manifestations of Primary Hyperparathyroidism. J Bone Miner Res. 2022 11; 37(11):2330-2350.
-
Disparities in Time to Surgeon Evaluation Among Patients with Primary Hyperparathyroidism. Surgery. 2023 Jan; 173(1):103-110.
-
Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemia. BMC Nephrol. 2022 06 17; 23(1):212.
-
Parathyroid Computed Tomography: Pearls, Pitfalls, and Our Approach. Neuroimaging Clin N Am. 2022 May; 32(2):413-431.